Literature DB >> 24331860

Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4.

Michelle C Fox, Colleen M Krajewski.   

Abstract

For a dilation and evacuation (D&E) procedure, the cervix must be dilated sufficiently to allow passage of operative instruments and products of conception without injuring the uterus or cervical canal. Preoperative preparation of the cervix reduces the risk of cervical laceration and uterine perforation. The cervix may be prepared with osmotic dilators, pharmacologic agents or both. Dilapan-S™ and laminaria are the two osmotic dilators currently available in the United States. Laminaria tents, made from dehydrated seaweed, require 12-24 h to achieve maximum dilation. Dilapan-S™, made of synthetic hydrogel, achieves significant dilation within 4 h and is thus preferable for same-day procedures. A single set of one to several dilators is usually adequate for D&E before 20 weeks' gestation. Misoprostol, a prostaglandin E1 analogue, is sometimes used instead of osmotic dilators. It is generally regarded as safe and effective; however, misoprostol achieves less dilation than overnight osmotic tents. The literature supports same-day cervical preparation with misoprostol or Dilapan-S™ up to 18 weeks' gestation. As the evidence regarding alternative regimens increases, highly experienced D&E providers may consider same-day regimens at later gestations utilizing serial doses of misoprostol or a combination of osmotic and pharmacologic agents. Misoprostol use as an adjunct to overnight osmotic dilation is not significantly beneficial before 19 weeks' gestation. Limited data demonstrate the safety of misoprostol before D&E in patients with a prior cesarean delivery. Mifepristone, a progesterone receptor antagonist, is also effective for cervical preparation prior to D&E, although data to support its use are limited. The Society of Family Planning recommends preoperative cervical preparation to decrease the risk of complications when performing a D&E. Since no single protocol has been found to be superior in all situations, clinical judgment is warranted when selecting a method of cervical preparation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical dilation; Cervical priming; Dilapan; Dilation and evacuation; Dilator; Lamicel; Laminaria; Mifepristone; Misoprostol

Mesh:

Substances:

Year:  2013        PMID: 24331860     DOI: 10.1016/j.contraception.2013.11.001

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

1.  Factors associated with abortion at 12 or more weeks gestation after implementation of a restrictive Texas law.

Authors:  Vinita Goyal; Robin Wallace; Amna I Dermish; Bhavik Kumar; Ann Schutt-Ainé; Anitra Beasley; Abigail R A Aiken
Journal:  Contraception       Date:  2020-06-25       Impact factor: 3.375

2.  Pain, Side Effects, and Abortion Experience Among People Seeking Abortion Care in the Second Trimester.

Authors:  Ilana G Dzuba; Sruthi Chandrasekaran; Laura Fix; Kelly Blanchard; Erin King
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-05-12

3.  Successful dilation and evacuation for second trimester conjoined twin: a case report and review of the literature.

Authors:  Ferid A Abubeker; Tesfaye H Tufa; Matiyas Asrat Shiferaw; Mekdes Daba Feyssa; Wondimu Gudu; Delayehu Bekele; Sarah Prager
Journal:  J Med Case Rep       Date:  2021-05-21

4.  Uterine rupture disguised by urinary retention following a second trimester induced abortion: a case report.

Authors:  Qiaoying Jiang; Liwei Yang; Charles Ashley; Erin E Medlin; David M Kushner; Yanmei Zheng
Journal:  BMC Womens Health       Date:  2015-01-22       Impact factor: 2.809

5.  Chronic Pelvic Pain and Infertility Resulting from Unrecognized Retained Laminaria.

Authors:  Wesley Nilsson; Sasha Mikhael; Jennifer Kaplan
Journal:  Case Rep Obstet Gynecol       Date:  2017-08-28

6.  Leukocytosis during cervical preparation with osmotic dilators for dilation and evacuation.

Authors:  Lyndsey S Benson; Jordan Stevens; Elizabeth A Micks; Sarah W Prager
Journal:  SAGE Open Med       Date:  2021-01-12

7.  Oral sedation for pain with cervical dilator placement: a randomized controlled trial.

Authors:  Jessica K Lee; Anne E Burke; Katrina Thaler; Jennifer A Robinson; Carolyn Sufrin
Journal:  Contracept X       Date:  2021-01-07

8.  Obstetric Outcomes after Perforation of Uterine Cavity.

Authors:  Polina Schwarzman; Yael Baumfeld; Salvatore Andrea Mastrolia; Shimrit Yaniv-Salem; Elad Leron; Tali Silberstein
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

9.  Access to later abortion in the United States during COVID-19: challenges and recommendations from providers, advocates, and researchers.

Authors:  Samantha Ruggiero; Kristyn Brandi; Alice Mark; Maureen Paul; Matthew F Reeves; Odile Schalit; Kelly Blanchard; Katherine Key; Sruthi Chandrasekaran
Journal:  Sex Reprod Health Matters       Date:  2020-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.